| Company Name: | Medwave inc | | Ticker Symbol: | MDWV | | | WWW Address: | www.mdwv.com |
| CEO: | Frank A. Katarow | | No. of Employees: | 22 |
| Common Issue Type: | CS | | Business Description: | The Company is engaged exclusively in the development, manufacture and sale of a non-invasive, continual blood pressure measurement and monitoring system and of related technology.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.0012 |  0.0 | 0.0011 | 0.0025 | | 0.20 | 0.16 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 0.0 | 13.1 | -0.32 | -0.47 | 0.00 | 0.0 | 0.0 | 2.49 - 0.13 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.20 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 0.0 | mil |
| Latest Shares Outstanding | 13.1 | mil |
| Earnings pS (EPS) | -0.47 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 50,784 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 11.6 | mil |
| Float as % of Shares Outstanding | 88.6 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 565.40 | % |
| Research & Devlopment (R&D) as % of Revenue | 111.80 | % |
| Gross Profit Margin | -0.7 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.1 | % |
| Return on Assets (ROA) | -89.1 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -110.9 | % |
| Current Ratio | 4.5 | |
| Leverage Ratio (Assets/Equity) | 1.2 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 0.19 | $ |
| Cash pS | 0.17 | $ |
| Book-Value pS | 0.22 | $ |
| Tangible Book-Value pS | 0.22 | $ |
| Cash Flow pS | -0.43 | $ |
| Free Cash Flow pS | -0.41 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 0.91 | |
| Price/Tangible Book Ratio | 0.91 | |
| Price/Cash Flow | -0.5 | |
| Price/Free Cash Flow | -0.5 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -31.0 | 68 | 551 | 4,745 |
| 4 Weeks | 0.35 | 0.13 | 0.32 | -37.5 | 62 | 371 | 7,058 |
| 13 Weeks | 0.46 | 0.13 | 0.27 | -25.9 | 69 | 438 | 27,563 |
| 26 Weeks | 0.54 | 0.13 | 0.44 | -54.5 | 42 | 681 | 85,071 |
| 52 Weeks | 2.49 | 0.13 | 2.33 | -91.4 | 7 | 715 | 178,720 |
| YTD | 0.60 | 0.13 | - | -65.5 | 32 | 707 | 94,030 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.22 | 0.26 | 0.29 | 0.34 | 0.59 | -0.32 | 1.53 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 3.46 | 3.1 | 16.19 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 61.91 | NA | 130.30 |
| R&D | 16.03 | NA | 85.43 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -39.6 | -51.7 | -4.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.03 | 0.03 | -0.09 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 67.78 |
| Current Ratio | 3.7 |
| Quick Ratio (Acid Test) | 3.1 |
| Liquidity Ratio (Cash) | 2.99 |
| Receivables Turnover | 4.8 |
| Average Collection Period | 75 |
| Working Capital/Equity | 90.4 |
| Working Capital pS | 0.32 |
| Cash-Flow pS | -0.43 |
| Free Cash-Flow pS | -0.37 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | -2.33 |
| Financial Leverage Ratio (Assets/Equity) | 1.3 |
| Debt Ratio | 25.0 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 0.0 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.29 |
| Tobin's Q Ratio | 0.42 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 0.09 |
| Enterprise Value (EV)/Free Cash Flow | 0.20 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 0.91 |
| Price/Book Ratio - LTM | 0.91 |
| Price/Cash Flow Ratio | -0.5 |
| Price/Free Cash Flow Ratio - LTM | -0.5 |
| Price/Sales Ratio | 3.33 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 0.12 |
| Tangible Book Value pS - LTM | 0.22 |
| Book Value pS - LTM | 0.22 |
| Capital Invested pS | 0.36 |
| Cash pS - LTM | 0.17 |
| Cash Flow pS - LTM | -0.43 |
| Free Cash Flow pS - LTM | -0.41 |
| Earnings pS (EPS) | -0.47 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -429.52 |
| Free Cash Flow Margin 5YEAR AVG | -308.57 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 0.0 |
| Equity Productivity | 0.24 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.24 |
| Return on Capital Invested (ROCI) | -123.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -77.3 |
| Assets Productivity | 0.20 |
| Return on Assets (ROA) | -92.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | -65.2 |
| Gross Profit Margin | -0.7 |
| Gross Profit Margin - 5YEAR AVRG. | 35.5 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 0.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 0.0 |
| Effective Tax Rate | 0.0 |
| Effective Tax Rate - 5YEAR AVRG. | 0.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 331 |
| Revenue per Employee | 50,784 |
| Net Income per Employee | -263,816 |
| Average Collection Period | 50 |
| Receivables Turnover | 4.8 |
| Day's Inventory Turnover Ratio | 281 |
| Inventory Turnover | 1.3 |
| Inventory/Sales | 77.0 |
| Accounts Payble/Sales | 49.89 |
| Assets/Revenue | 5.00 |
| Net Working Capital Turnover | 0.26 |
| Fixed Assets Turnover | 2.48 |
| Total Assets Turnover | 0.2 |
| Revenue per $ Cash | 0.24 |
| Revenue per $ Plant | 2.48 |
| Revenue per $ Common Equity | 0.24 |
| Revenue per $ Capital Invested | 0.24 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 420.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 292.8 |
| Research & Devlopment (R&D) as % of Revenue | 83.1 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 83.1 |
|
|  
|
| |
 |  |
